Search
NewAmsterdam Pharma Company NV
NAMSAdd to Watchlist
27.790USD
-0.670-2.35%
Close 07-31 16:00（ET）Quotes delayed by 15 min
3.25BMarket Cap
LossP/E TTM
NAMS Financials
See NewAmsterdam Pharma Company NV's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
NewAmsterdam Pharma Company NV Earnings Date
Latest Release
May 7, 2026
EPS / Forecast
-0.40/-0.49
Revenue / Forecast
3.04M/936.36K
Period
FY2025 Earnings
Revenue(YoY)
22.50M
-50.61%
EPS(YoY)
-1.72
32.78%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its total revenue reached 22.50M, with a year-on-year change of 45.56M.
What are the current assets of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its current assets were 675.70M, with a year-on-year change of -21.74.
What are the total assets of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its total assets of NewAmsterdam Pharma Company NV were 769.28M, with a year-on-year change of -11.03.
What are the total liabilities of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its total liabilities of NewAmsterdam Pharma Company NV were 85.85M, with a year-on-year change of -19.85.
What is the total equity of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its total equity of NewAmsterdam Pharma Company NV was 683.43M, with a year-on-year change of -9.78.
What is the net operating income of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its net operating income of NewAmsterdam Pharma Company NV was -225.68M, with a year-on-year change of -28.02.
What is the net investment of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its net investment of NewAmsterdam Pharma Company NV was -174.92M, with a year-on-year change of -178.32.
What is the net financing of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its net financing of NewAmsterdam Pharma Company NV was 29.52M, with a year-on-year change of -95.52.
What is the Earnings Per Share (EPS) of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its Earnings Per Share (EPS) was -1.72, with a year-on-year change of 32.78.
What is the net income of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its net income was -203.82M, with a year-on-year change of 15.64.
What is the net margin of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its net profit margin was -905.74, with a year-on-year change of -70.81.
What is the Return on Equity (ROE) of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its Return on Equity (ROE) was -28.29, with a year-on-year change of 38.77.
What is the Return on Assets (ROA) of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its Return on Assets (ROA) was -24.95, with a year-on-year change of 37.44.
What is the operating profit of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2025 earnings report, its operating profit was -225.68M, with a year-on-year change of -28.02.